rivaroxaban
Showing 51 - 75 of 153
Drug Interaction Study Trial in Bern (St Johns Wort Extract, Rivaroxaban)
Completed
- Drug Interaction Study
- St Johns Wort Extract
- Rivaroxaban
-
Bern, SwitzerlandInselspital
Oct 30, 2020
NOACs in Oral and Maxillofacial Surgery: Impact on
Recruiting
- Surgery, Oral
- +5 more
- Type of surgery
- +5 more
-
Helsingborg, Sweden
- +1 more
Apr 11, 2022
Mitral Stenosis, Rheumatic Heart Disease, Atrial Fibrillation Trial in Tehran (Rivaroxaban, Warfarin)
Terminated
- Mitral Stenosis
- +3 more
- Rivaroxaban
- Warfarin
-
Tehran, Iran, Islamic Republic ofRajaie Cardiovascular Medical and Research Center
Aug 14, 2021
ATRIAL FIBRILLATION Trial in Montreal (Rivaroxaban, standard of care)
Recruiting
- ATRIAL FIBRILLATION
- Rivaroxaban
- standard of care
-
Montreal, Quebec, CanadaMontreal Heart Institute
Sep 24, 2021
Atrial Fibrillation (AF), Stroke Trial in Worldwide (Abelacimab, Rivaroxaban)
Active, not recruiting
- Atrial Fibrillation (AF)
- Stroke
- Abelacimab
- Rivaroxaban
-
Huntsville, Alabama
- +93 more
Jan 25, 2023
Cerebral Vein Thrombosis Trial in Damascus (Rivaroxaban, Warfarin)
Completed
- Cerebral Vein Thrombosis
- Rivaroxaban
- Warfarin
-
Damascus, Damascus Governorate, Syrian Arab RepublicDamascus University
Sep 24, 2020
Healthy Trial in Secaucus (Ciraparantag, Placebo, Rivaroxaban)
Completed
- Healthy
- Ciraparantag
- +2 more
-
Secaucus, New JerseyFrontage Clinical Services Inc.
Sep 2, 2020
Liver Cirrhosis Trial in China (Rivaroxaban)
Recruiting
- Liver Cirrhosis
- Rivaroxaban
-
Guangzhou, Guangdong, China
- +10 more
Oct 22, 2022
Rivaroxaban Used in Extended Anticoagulation for Pulmonary
Not yet recruiting
- Pulmonary Embolism
- Rivaroxaban
- (no location specified)
Aug 25, 2020
Deep Vein Thrombosis, Iliac Vein Thrombosis, Iliac Vein Obstruction Trial in Hangzhou (Rivaroxaban, Aspirin)
Recruiting
- Deep Vein Thrombosis
- +4 more
- Rivaroxaban
- Aspirin
-
Hangzhou, Zhejiang, ChinaThe First Affliated Hospital, Zhejiang University, School of Med
Dec 13, 2021
Coagulation Disorder Trial in Groningen (VMX-C001, Placebo, Apixaban)
Recruiting
- Coagulation Disorder
- VMX-C001
- +4 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Dec 7, 2021
Replication of EINSTEIN-PE Anticoagulant Trial in Healthcare
Active, not recruiting
- Pulmonary Embolism
- Rivaroxaban
- Warfarin
-
Boston, MassachusettsBrigham and Women's Hospital
May 6, 2021
Replication of EINSTEIN-DVT Anticoagulant Trial in Healthcare
Completed
- Venous Thromboembolism
- Rivaroxaban
- Warfarin
-
Boston, MassachusettsBrigham and Women's Hospital
May 6, 2021
May-Thurner Syndrome Trial in China (Rivaroxaban, Warfarin, Nadroparin)
Recruiting
- May-Thurner Syndrome
- Rivaroxaban
- +2 more
-
Hefei, Anhui, China
- +8 more
Dec 29, 2020
Non-Vitamin K Oral Anticoagulants in Older Atrial Fibrillation
Active, not recruiting
- Atrial Fibrillation
- +3 more
- Warfarin
- +4 more
-
Boston, MassachusettsBrigham and Women's Hospital
May 5, 2021
Pulmonary Embolism, Venous Thrombosis Trial in Canada, United States (Enteric Coated Aspirin, Warfarin, Rivaroxaban)
Recruiting
- Pulmonary Embolism
- Venous Thrombosis
- Enteric Coated Aspirin
- +2 more
-
Scottsdale, Arizona
- +30 more
Nov 3, 2022
Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Stroke Trial (Rivaroxaban, Warfarin)
Not yet recruiting
- Antiphospholipid Syndrome
- +4 more
- Rivaroxaban
- Warfarin
- (no location specified)
Jul 15, 2020
Rivaroxaban, Thromboprophylaxis, Cancer Trial (Rivaroxaban)
Unknown status
- Rivaroxaban
- +2 more
- Rivaroxaban
- (no location specified)
Mar 12, 2020
Anticoagulant-induced Bleeding Trial in Quebec (Warfarin, Dabigatran, Rivaroxaban)
Not yet recruiting
- Anticoagulant-induced Bleeding
- Warfarin
- +4 more
-
Quebec, CanadaInstitut Universitaire de Cardiologie et de Pneumologie de Quebe
Feb 17, 2021
Atrial Fibrillation Trial in Roma (Rivaroxaban, Catheter ablation)
Unknown status
- Atrial Fibrillation
- Rivaroxaban
- Catheter ablation
-
Roma, ItalyAzienda Ospedaliero-Universitaria Policlinico Umberto I - Dipart
Jun 4, 2020
Sickle Cell Anemia, Sickle Cell-Beta0-Thalassemia Trial in Chapel Hill (rivaroxaban, )
Completed
- Sickle Cell Anemia
- Sickle Cell-Beta0-Thalassemia
- rivaroxaban
- placebo
-
Chapel Hill, North CarolinaUniversity of North Carolina - Chapel Hill
Apr 9, 2020
Renal Insufficiency Trial in France (Apixaban, Rivaroxaban, Heparin)
Active, not recruiting
- Renal Insufficiency
- Apixaban
- +3 more
-
Arras, Boulevard Georges Besnier, France
- +30 more
Feb 2, 2022
Replication of ROCKET-AF Anticoagulant Trial in Healthcare
Unknown status
- Atrial Fibrillation
- Warfarin
- Rivaroxaban
-
Boston, MassachusettsBrigham And Women's Hospital
Oct 13, 2020